Equities

Global Pharmatech Inc

GBLP:PKC

Global Pharmatech Inc

Actions
  • Price (USD)0.17
  • Today's Change0.00 / 0.00%
  • Shares traded750.00
  • 1 Year change-15.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 15:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Global Pharmatech, Inc., formerly Global Pharmatech Pvt. Ltd., is a contract manufacturer of liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles The Company has manufactured products in various therapeutic segments such as Vitamin Supplements, Anaesthetics, Corticosteroids, Anti-emetics, Steroids with antibiotics, Anemia, Analgesics, Antihistamines, Anti Filarial. Its first product, Iron Sucrose, is being marketed in India. It offers the products for domestic as well as international market. Its products include Iron Sucrose Injection USP, Ondansetron Injection USP, Promethazine Injection BP, Tramadol HCI Injection, Metoclopramide Injection BP, Levetiracetam Injection and Amikacin Injection. The Company registers products in various markets around the world.

  • Revenue in USD (TTM)3.18m
  • Net income in USD-2.24m
  • Incorporated2001
  • Employees217.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Immix Biopharma Inc0.00-21.89m46.12m14.00--2.63-----0.8536-0.85360.000.63870.00----0.00-92.58---114.95--------------0.00-------87.44------
Odonate Inc0.00-102.07m49.87m137.00--1,839.01-----13.59-13.590.009.270.00----0.00-66.98-58.36-83.00-65.14------------0.00-------12.99------
BGM Group Ltd29.87m-7.86m50.59m298.00--1.15--1.69-1.10-1.104.186.070.52373.7325.96100,236.40-14.432.71-17.013.862.9211.66-27.562.726.06-0.75270.0026.11-28.35-1.60-822.64--12.86--
Aadi Bioscience Inc25.07m-61.69m56.20m53.00--0.8149--2.24-2.29-2.290.92852.800.22250.6964.09281,685.40-54.75-50.25-65.27-56.1587.39---246.06-473.974.54--0.00--60.063.85-8.68--153.54--
bluebird bio Inc53.12m-300.52m57.77m375.00------1.09-1.84-1.840.3039-0.02980.09852.034.42141,653.30-55.72-34.75-96.37-40.84-43.49-124.35-565.74-5,770.410.3272-13.371.03--720.04-11.588.00---30.47--
OptiNose Inc75.67m-31.15m59.56m132.00------0.787-0.2216-0.22160.5416-0.27250.65120.76592.96573,272.80-26.80-48.25---98.9590.2186.96-41.16-131.660.7198-1.611.48---6.9358.6452.58---27.96--
Cellectar Biosciences Inc0.00-49.67m64.10m20.00--41.37-----1.67-1.670.000.40790.00----0.00-168.84-83.69-450.38-99.80------------0.00-------32.80--17.55--
Hongchang International Co Ltd5.42m-208.79k66.15m8.00--1.63--12.21-0.0004-0.00040.01040.07840.09915.5037.20---0.2731-7.98-0.2965-10.944.5111.47-2.76-64.884.64--0.3169--3,289.22---42.63------
Global Pharmatech Inc.3.18m-2.24m67.19m217.00--0.4959--21.13-0.0964-0.09640.13670.34280.22921.593.5714,649.77-16.44---22.55--46.21---71.75--1.62-9.870.2223--32.43---142.03------
CASI Pharmaceuticals Inc22.06m-30.97m70.36m176.00--5.08--3.19-2.23-2.231.591.030.320.92652.03125,312.50-43.04-34.75-66.19-46.9154.3155.98-134.50-153.722.32--0.58---21.41--34.27--14.65--
Rockwell Medical Inc98.92m-1.24m71.10m237.00--2.4449.860.7188-0.0496-0.04963.230.90151.8014.4510.84417,371.30-2.25-46.29-3.34-65.3816.914.66-1.25-36.512.000.31940.2654--14.845.6954.82--76.21--
Journey Medical Corp57.77m-18.34m77.43m58.00--9.87--1.34-0.9276-0.92762.930.52710.8892.166.19996,051.80-28.22---76.21--57.32---31.74--1.03-13.650.6582--7.48--87.00------
I-Mab ADR-100.00bn-100.00bn77.57m220.00--0.33----------2.91-----------35.51---41.43-------509.54----0.00--111.86-13.6544.45---5.95--
Data as of Nov 13 2024. Currency figures normalised to Global Pharmatech Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.